Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India

Background: Acute leukemia of ambiguous lineage (ALAL) is a heterogeneous group of rare leukemias that lacks definite evidence of differentiation along one lineage. It includes acute undifferentiated leukemia and mixed-phenotype acute Leukaemia (MPAL). Aims: The present study highlighted the clinico...

Full description

Saved in:
Bibliographic Details
Main Authors: Varnika Rai, Beena Brahmbhatt, Anurag Saha, Immanuel P. Thayakaran
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-07-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:https://journals.lww.com/10.4103/ijpm.ijpm_59_22
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832591259541176320
author Varnika Rai
Beena Brahmbhatt
Anurag Saha
Immanuel P. Thayakaran
author_facet Varnika Rai
Beena Brahmbhatt
Anurag Saha
Immanuel P. Thayakaran
author_sort Varnika Rai
collection DOAJ
description Background: Acute leukemia of ambiguous lineage (ALAL) is a heterogeneous group of rare leukemias that lacks definite evidence of differentiation along one lineage. It includes acute undifferentiated leukemia and mixed-phenotype acute Leukaemia (MPAL). Aims: The present study highlighted the clinicohematological and immunophenotypic profile of ALAL cases diagnosed in the tertiary care centre of western India. Study Design: Retrospective observational study. Methods and Materials: Patients diagnosed with acute leukemia, preferably their bone marrow aspirate samples, were collected in ethylene diamine tetra-acetic acid-vial. The immunophenotypic study was done using the Fluorescence Activated Cell Sorting (FACS) Canto Eight color flow cytometer and a broad panel of monoclonal antibodies. The patients were diagnosed for ALAL, based on the World Health Organization (WHO) 2017 classification. Statistical Analysis Used: Descriptive statistics with categorical and continuous variables. Results: Overall incidence of ALAL was about 2.1%, and singly MPAL and AUL were 1.8%, and 0.3%, in frequency, respectively. The age range was 4 to 57 (median age 21 years), of which 11 (57.9%) were adults and eight were children (42.1%). There was male predominance with Male: Female ratio of 5.3:1. On immunophenotyping, B/myeloid MPAL (42.1%) was the commonest among the ALAL. Translocation t(9;22) was the most common cytogenetic abnormality found mainly in B/myeloid MPAL. Two cases were of chronic myeloid leukemia in a mixed phenotypic blast crisis. Over all prognosis of ALAL was poor. Conclusion: ALAL is overall associated with poor prognosis as both their diagnosis and treatment decisions are difficult owing to the lack of optimum treatment data and the rarity of the disease. Hence, A careful diagnosis with the help of immunophenotyping is crucial.
format Article
id doaj-art-bf3e8c57a4df4ba2a326676750bc7bb7
institution Kabale University
issn 0377-4929
0974-5130
language English
publishDate 2023-07-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Indian Journal of Pathology and Microbiology
spelling doaj-art-bf3e8c57a4df4ba2a326676750bc7bb72025-01-22T15:11:12ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49290974-51302023-07-0167112112710.4103/ijpm.ijpm_59_22Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West IndiaVarnika RaiBeena BrahmbhattAnurag SahaImmanuel P. ThayakaranBackground: Acute leukemia of ambiguous lineage (ALAL) is a heterogeneous group of rare leukemias that lacks definite evidence of differentiation along one lineage. It includes acute undifferentiated leukemia and mixed-phenotype acute Leukaemia (MPAL). Aims: The present study highlighted the clinicohematological and immunophenotypic profile of ALAL cases diagnosed in the tertiary care centre of western India. Study Design: Retrospective observational study. Methods and Materials: Patients diagnosed with acute leukemia, preferably their bone marrow aspirate samples, were collected in ethylene diamine tetra-acetic acid-vial. The immunophenotypic study was done using the Fluorescence Activated Cell Sorting (FACS) Canto Eight color flow cytometer and a broad panel of monoclonal antibodies. The patients were diagnosed for ALAL, based on the World Health Organization (WHO) 2017 classification. Statistical Analysis Used: Descriptive statistics with categorical and continuous variables. Results: Overall incidence of ALAL was about 2.1%, and singly MPAL and AUL were 1.8%, and 0.3%, in frequency, respectively. The age range was 4 to 57 (median age 21 years), of which 11 (57.9%) were adults and eight were children (42.1%). There was male predominance with Male: Female ratio of 5.3:1. On immunophenotyping, B/myeloid MPAL (42.1%) was the commonest among the ALAL. Translocation t(9;22) was the most common cytogenetic abnormality found mainly in B/myeloid MPAL. Two cases were of chronic myeloid leukemia in a mixed phenotypic blast crisis. Over all prognosis of ALAL was poor. Conclusion: ALAL is overall associated with poor prognosis as both their diagnosis and treatment decisions are difficult owing to the lack of optimum treatment data and the rarity of the disease. Hence, A careful diagnosis with the help of immunophenotyping is crucial.https://journals.lww.com/10.4103/ijpm.ijpm_59_22acute leukemia of ambiguous lineageacute undifferentiated leukemiaimmunophenotypingmixed phenotypic acute leukemia
spellingShingle Varnika Rai
Beena Brahmbhatt
Anurag Saha
Immanuel P. Thayakaran
Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India
Indian Journal of Pathology and Microbiology
acute leukemia of ambiguous lineage
acute undifferentiated leukemia
immunophenotyping
mixed phenotypic acute leukemia
title Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India
title_full Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India
title_fullStr Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India
title_full_unstemmed Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India
title_short Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India
title_sort clinico hematological and immunophenotypic profile of acute leukemia of ambiguous lineage a four year experience from a single tertiary care centre of west india
topic acute leukemia of ambiguous lineage
acute undifferentiated leukemia
immunophenotyping
mixed phenotypic acute leukemia
url https://journals.lww.com/10.4103/ijpm.ijpm_59_22
work_keys_str_mv AT varnikarai clinicohematologicalandimmunophenotypicprofileofacuteleukemiaofambiguouslineageafouryearexperiencefromasingletertiarycarecentreofwestindia
AT beenabrahmbhatt clinicohematologicalandimmunophenotypicprofileofacuteleukemiaofambiguouslineageafouryearexperiencefromasingletertiarycarecentreofwestindia
AT anuragsaha clinicohematologicalandimmunophenotypicprofileofacuteleukemiaofambiguouslineageafouryearexperiencefromasingletertiarycarecentreofwestindia
AT immanuelpthayakaran clinicohematologicalandimmunophenotypicprofileofacuteleukemiaofambiguouslineageafouryearexperiencefromasingletertiarycarecentreofwestindia